Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 49.38 8.05%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Halozyme Therapeutics Long Term Debt 2011-2024 | HALO

Annual Long Term Debt Halozyme Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.5 B 1.49 B 787 M 397 M 383 M 34.9 M 125 M 199 M 28 M 49.9 M 49.8 M 29.7 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.5 B 28 M 423 M

Quarterly Long Term Debt Halozyme Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
1.5 B 1.5 B 1.5 B 1.5 B 1.5 B 1.5 B 1.49 B 1.49 B 1.49 B 1.15 B 788 M 787 M 786 M 786 M 785 M - - - - 383 M 383 M 383 M 383 M 34.9 M 34.9 M 34.9 M 34.9 M 125 M 125 M 125 M 125 M 199 M 199 M 199 M 199 M 28 M 28 M 28 M 28 M 49.9 M 49.9 M 49.9 M 49.9 M 49.8 M 49.8 M 49.8 M 49.8 M 29.7 M 29.7 M 29.7 M 29.7 M - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.5 B 28 M 471 M